A case of long - term extracorporeal membrane oxygenation in the treatment of acute respiratory distress syndrome in a patient with COVID-19

E. V Kryukov; Крюков Е. В; V. A Chernetsov; Чернецов В. А; A. E Shestopalov; Шестопалов А. Е; V. V Stets; Стец В. В; A. G Zhuravlev; Журавлев А. Г; V. V Morgachev; Моргачев В. В; D. S Meshcheryakov; Мещеряков Д. С

doi:10.17816/RMMJ82540

A case of long - term extracorporeal membrane oxygenation in the treatment of acute respiratory distress syndrome in a patient with COVID-19

Authors: Kryukov E.V¹, Chernetsov V.A¹, Shestopalov A.E¹, Stets V.V¹, Zhuravlev A.G¹, Morgachev V.V¹, Meshcheryakov D.S¹
Affiliations:
1. The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Issue: Vol 342, No 1 (2021)
Pages: 76-79
Section: Articles
URL: https://journals.eco-vector.com/0026-9050/article/view/82540
DOI: https://doi.org/10.17816/RMMJ82540
ID: 82540

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription Access

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

The most common clinical manifestation of COVID-19 is a bilateral lung disease, with acute respiratory distress syndrome (ARDS) developing in 3-4% of cases. The experience of using extracorporeal membrane oxygenation with the ineffectiveness of mechanical ventilation in the treatment of ARDS in patients with coronavirus infection is insignificant. The article demonstrates a case of long - term (30 days) use of extracorporeal membrane oxygenation in a patient with viral total lung disease, CT-4, severe acute respiratory distress syndrome. The possibility and efficiency of the long - term application of the method are presented. Anticoagulant therapy using low molecular weight heparin (enoxaparin) is adequate, reduces the risk of bleeding, determines the duration and effectiveness of using a membrane oxygenator, and reduces the likelihood of thrombosis of the extracorporeal circuit, and preserves its oxygenating function.

Keywords

COVID-19, extracorporeal membrane oxygenation, acute respiratory distress syndrome, COVID-19, viral total lung disease, coagulopathy

Full Text

References

Abrams D., Ferguson N., Brochard L. et al. ECMO for ARDS: from salvage to standard of care? // The Lancet Respiratory Medicine. - 2019. - Vol. 7, N 2. - P. 108-110.
Extracorporeal Life Support Organization, General Guidelines for all ECLS Cases, 2019.
https://sccm.org/SurvivingSepsisCampaign /Guidelines/COVID-19
https://www.eurolso.net/ Guidelines for ECMO in COVID-19
https://www.elso.org/Resources/Guide lines.aspx
Li M., Gu S-Ch., Wu X-C. et al. Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease: indications, timing, and implementation // Chinese Med. J. - 2020. - Vol. 133, N 9. - P. 1115-1117.
Ramanathan K., Antognini D., Combes A. et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases // Lancet Respir Med. - 2020. - Vol. 8, Iss. 5. - P. 518-526.

Supplementary files

Supplementary Files

Action

1. JATS XML

Download

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register

A case of long - term extracorporeal membrane oxygenation in the treatment of acute respiratory distress syndrome in a patient with COVID-19

Full Text

Abstract

Keywords

Full Text

About the authors

E. V Kryukov

V. A Chernetsov

A. E Shestopalov

V. V Stets

A. G Zhuravlev

V. V Morgachev

D. S Meshcheryakov

References

Supplementary files

This website uses cookies